Artelo Biosciences (ARTL) Net Shares Issued and Repurchased (2019 - 2025)

Artelo Biosciences (ARTL) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $98866.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 133.08% year-over-year to $98866.0 in Q4 2025; TTM through Dec 2025 was $98866.0, a 133.08% increase from a year earlier, with the FY2025 full-year figure at $98866.0, up 133.08% from the prior year.
• Net Shares Issued and Repurchased was $98866.0 for Q4 2025 at Artelo Biosciences, up from $42417.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $2.8 billion in Q3 2021 and troughed at $25548.0 in Q4 2022.
• A 5-year average of $421.6 million and a median of $205996.0 in 2023 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased surged 3623.11% in 2021 and plunged 99.88% in 2024, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.8 billion in 2021, then tumbled by 100.0% to $25548.0 in 2022, then jumped by 706.31% to $205996.0 in 2023, then plunged by 79.41% to $42417.0 in 2024, then soared by 133.08% to $98866.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $98866.0 (Q4 2025), $42417.0 (Q4 2024), and $244000.0 (Q1 2024), per Business Quant data.